Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
12/2010
12/16/2010US20100314615 Aromatic amine derivative and organic electroluminescent device using the same
12/16/2010CA2764430A1 Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof
12/15/2010EP2260051A1 Glucopyranoside derivatives
12/15/2010CN101914093A Reactive heterocycle-substituted 7-hydroxycoumarins and their conjugates
12/15/2010CN101012211B Substituted andrographolide derivative, preparing method and pharmaceutical compound thereof
12/14/2010CA2430909C Inhibitors of papilloma virus
12/09/2010US20100311931 Catalyst Systems Based on Carbonylamino Fulvenes
12/09/2010US20100311795 1,3-dioxane carboxylic acids
12/09/2010US20100311778 Chromane derivatives as trpv3 modulators
12/09/2010US20100310615 Compositions comprising stilbene polyphenol derivatives and use thereof for combating the ageing of living organisms and diseases affecting same
12/08/2010EP2258708A1 Macrolide compounds endowed with antiinflammatory activity
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010CN1611495B Compound having an epoxy group and a chalcone group, method of preparing the same, and photoresist composition comprising the same
12/08/2010CN101910145A Heterocyclic antiviral compounds
12/08/2010CN101910129A Synthesis of quaternary salt compounds
12/07/2010US7846945 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents
12/02/2010WO2010137018A1 Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010US20100305313 Extraction process for plant ingredients
12/02/2010US20100305299 Biphenyltetracarboxylic acid dianhydride and process for producing the same, and polyimide formed from the same and process for producing the same
12/02/2010US20100305182 Compounds and methods for modulating communication and virulence in quorum sensing bacteria
12/02/2010US20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010US20100301313 Benzanthracene compound and organic electroluminescence device using the same
12/01/2010EP2254410A1 Methods for inhibiting drug degradation
12/01/2010CN101903378A Aminotriazole derivatives
12/01/2010CN101903373A Functionally selective alpha2c adrenoreceptor agonists
12/01/2010CN101903357A Cyclic amine substituted pyrimidinediamines as PKC inhibitors
12/01/2010CN101902914A Azolylmethyloxiranes, use thereof and agents containing the same
12/01/2010CN101902912A Fungicidal amines
12/01/2010CN101899041A Superior medicinal crystal-form solid substance of puerarin as well as preparation method and application thereof
12/01/2010CN101353327B Aryl substituted pyrimidine spirobifluorene derivative and preparation thereof
12/01/2010CN101307226B Fluorochrome for marking oligonucleotide and protein, method for preparing same and use
12/01/2010CN100999520B Isoandrographolide analogue and its preparation process
11/2010
11/30/2010US7842712 Indazolinone compositions useful as kinase inhibitors
11/30/2010CA2456239C Intermediates for preparing neuraminidase inhibitor conjugates
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010WO2010135427A2 Trioxane monomers and dimers
11/25/2010WO2010133569A1 Azabicyclo[4.1.0]heptane derivatives
11/25/2010WO2010056585A3 Heteroaryl diamide compounds useful as mmp-13 inhibitors
11/25/2010WO2009132202A3 Macrocyclic compounds and their use as kinase inhibitors
11/25/2010US20100298577 Multifunctional Dendrons and Dendrimers with a High Loading Capacity
11/25/2010US20100298573 Fluorescent agent having ethynyl group
11/25/2010US20100298346 Nitrogenous heterocyclic compounds with insecticidal activity, and the preparation and use thereof
11/25/2010US20100298345 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
11/25/2010US20100297541 Sulphonium salt initiators
11/25/2010US20100297540 Sulphonium salt initiators
11/24/2010EP2252597A2 Novel compounds, use and preparation thereof
11/23/2010US7838694 Preparation of paclitaxel and docetaxel, 10-deacetylbaccatin III and baccatin III; antileukemic and tumor inhibitory activity
11/23/2010US7838689 An ionic liquid catalyst as both liquid carrier and catalyst along with metal halide promoters allow ready separation of the solid reaction composition from the liquid reaction mixture; efficiency, less waste; reuse; purity; phthalimidines as monomers for polycarbonate
11/23/2010US7838537 Viral polymerase inhibitors
11/23/2010US7837981 Methods for imaging soluble A-beta
11/18/2010WO2010132757A2 Antibacterial aminoglycoside analogs
11/18/2010WO2010132247A1 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010WO2010131669A1 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
11/18/2010WO2010130460A1 Amorphous silibinin for the treatment of viral hepatitis
11/18/2010WO2010076564A3 Isochromenones useful in the treatment of inflammation
11/18/2010WO2010059611A3 Inhibitors of diacylglycerol acyltransferase
11/18/2010US20100292491 Method of Making Ketals and Acetals
11/18/2010US20100292373 Adducts of levulinic derivatives with epoxidized fatty acid esters and uses thereof
11/18/2010US20100292190 Novel tubulin polymerisation inhibitors
11/18/2010US20100292187 Methods for treating hepatitis c
11/18/2010CA2761656A1 Amorphous silibinin for the treatment of viral hepatitis
11/17/2010EP1899296B1 Histamine-3 receptor antagonists
11/17/2010CN101888997A Synthesis of quaternary salt compounds
11/17/2010CN101885723A Mangiferin glycolipid derivant and preparation method thereof
11/16/2010US7834013 Racemic-(trans)-2-[4-({[3-(phenyloxy)phenyl]methyl}ammonium)phenyl]cyclopropanecarboxylic acid; type II diabetes; G protein-coupled receptor 40 (GPR40) agonists
11/16/2010US7833694 improved line edge roughness (LER) without sacrificing resolution; photoresists; immersion lithography; (meth)acrylic esters linked trough an alkyl chain conntect via another ester to a tricyclic lactone ring, such as 2,6-norbornane carbolactone
11/11/2010WO2010129467A1 Compounds and methods for inhibition of renin, and indications therefor
11/11/2010WO2010129379A1 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100286171 Phenylacetamide derivative
11/11/2010CA2761009A1 Compounds and methods for inhibition of renin, and indications therefor
11/11/2010CA2759399A1 Inhibitors of the renal outer medullary potassium channel
11/10/2010EP1653944B1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
11/10/2010CN101883764A Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
11/10/2010CN101880275A Puerarin monocrystal and preparation method thereof
11/10/2010CN101407512B Preparation of bicyclohexyl neopentyl glycol single ketal
11/10/2010CN101348560B Epoxide resin containing furan group and preparation thereof
11/04/2010WO2010125350A1 Treatment or prophylaxis of proliferative conditions
11/04/2010WO2010124648A1 Azaazulene compounds
11/04/2010WO2010089764A3 Improved process for preparation of nebivolol hydrochloride
11/04/2010US20100280246 Energy transfer dyes with enhanced fluorescence
11/04/2010US20100280186 Furanic-modified amine-based curatives
11/04/2010US20100280091 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disbustituted pyran derivatives
11/04/2010US20100280075 Paclitaxel enhancer compounds
11/04/2010US20100280066 Acylated amino acid amidyl pyrazoles and related compounds
11/04/2010US20100280013 Carbinol derivatives having heterocyclic linker
11/04/2010CA2759883A1 Treatment or prophylaxis of proliferative conditions
11/04/2010CA2747420A1 Azaazulene compounds
11/03/2010EP2245023A1 Heterocyclic antiviral compounds
11/03/2010EP1515966B1 Hydroxy pyranone derivative and preparation method thereof
11/03/2010CN101381363B Method for extracting macroporous adsorption resin and separating hepadestal from alkaline water
11/03/2010CN101302212B Preparation and use of silybum marianum di-partial succinate and salt thereof
11/02/2010CA2341520C Energy transfer dyes
10/2010
10/28/2010WO2010124047A1 Bisaryl alkynylamides as negative allosteric modulators of metabotropic glutamate receptor 5 (mglur5)
10/28/2010WO2010110646A8 Aurones as selective pde inhibitors and their use in neurological conditions and disorders
10/28/2010WO2010077976A3 Prokineticin receptor antagonists and uses thereof
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/27/2010EP2242741A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
10/21/2010WO2010121226A2 Anticancer agents
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 120